Korea's PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next-generation antibody thera...
China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...
Adge Pharmaceuticals has entered into a license agreement with South Korea-based Cyan Bio, Inc. Cyan will receive exclus...
Lynk Pharmaceuticals, an innovative clinical stage company, has announced that its Class I innovative drug LNK01004, has...
South Korea's LG Chem has announced that its Chinese counterpart TransThera Sciences received the IND clearance fro...
Pangaea Data, headquartered in London with offices in San Francisco and Hong Kong, is now a member of Innovati...
China-based startup ImmVira has reached a cooperation agreement with Roche to establish clinical research partnership re...
China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...
Japan-based Fujitsu has announced a key development in its global innovation strategy with the establishment of a new re...
UK's Engitix, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its propr...
Harbour BioMed has announced the appointment of Dr Humphrey Gardner as Chief Medical Officer (CMO). Dr Gardner...
Israel's CytoReason, a leading developer of computational disease models for efficient drug discovery and developme...
The Consortium for Clinical Research and Innovation, Singapore (CRIS) has been established to bring together five key na...
South Korea-based Daewoong Pharmaceutical and HanAll Biopharma have announced expansion of their open collabo...
US-based Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Bi...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. have reached an agreement with BeiGene (Beijing) for licensing of Biocyto...
Korea's OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has identified effective inhibition o...
Australia's Telix Pharmaceuticals has entered into a licence agreement with Eli Lilly and Company under which Telix is g...
University of Melbourne in Australia and Indian Institute of Science (IISc) have joined hands for the first-ever joint P...
China's CARsgen Therapeutics Holdings, a company focused on innovative CAR T cell therapies for the treatment of hematol...
Bened Biomedical has announced recent approval of the company's probiotic L. plantarum PS128 in Thailand and Canada. Aut...
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has received approval from Austr...
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical ...
Singlera Genomics has announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to...
